RxFul for clinics: who actually buys and uses it

An owner should evaluate RxFul on infrastructure ROI: which SaaS tier unlocks the catalog and branding you need, what fulfillment fees add on top, and whether patient-portal infrastructure is the bottleneck versus prescriber ops on refill day. An operations lead should evaluate fulfillment coordination: how pharmacy integration and 3PL handoffs work, what cold-chain and volume-based pricing mean on Silver, and how patient tracking comms reduce status calls.

A prescriber should evaluate whether the portal path fits how orders actually get placed in the clinic. If clinicians and staff batch dozens of refills in one session, a patient-portal-first stack may leave prescriber ops fragmented even when patient branding is strong. Each role's risk is different, but they share one fork — portal infrastructure versus prescriber batch checkout.

Fizy Health serves clinics whose bottleneck is prescriber and ops ordering, not launching a new patient storefront. The owner gets pass-through per-vial 503A cost on every catalog and cart line before checkout. The operations lead gets one clinic cart that batches every patient's order for refill day, with cart validation catching invalid SIGs, prescriber state mismatches, and stock gaps before payment.

The prescriber gets directions and licensure checked before the order is submitted, reducing post-pay rejections, plus per-line tracking from the clinic dashboard. Same 503A partner category as RxFul — but the owner, operator, and prescriber each get more decided on the staff side before money moves.